Adults with moderate to severe plaque psoriasis saw the greatest mean quality-of-life gains with biologic therapy whereas ...

A simulated analysis in psoriasis highlights divergent patient and payer incentives and inconsistent coverage strategies behind barriers to phototherapy uptake.

FDA approval covers adults and adolescents ≥12 years (≥88 lbs) with moderate-to-severe plaque psoriasis requiring systemic therapy or phototherapy, expanding systemic options beyond injectables.

It is unclear if high- versus low-dose phototherapy reduces the occurrence of newborn brain injuries, cerebral palsy, or death before leaving the hospital. High- versus low-dose phototherapy may ...

Shares of Protagonist Therapeutics PTGX have gained nearly 7% over the past week. The upside came after the company announced that the FDA had approved its partner, Johnson & Johnson JNJ’s icotrokinra ...

SAN DIEGO -- Home-based phototherapy for psoriasis achieved outcomes similar to office-based therapy, suggesting a potential for more convenient, less expensive treatment for some patients, according ...

This transcript has been edited for clarity. Steven R. Feldman, MD, PhD: Hi. Welcome to Medscape InDiscussion on psoriasis. I'm your host, Dr Steve Feldman. When psoriasis is extensive, it can have an ...

A retrospective cohort study found no significant associations between phototherapy without psoralens and the risk of skin cancer. Patients undergoing phototherapy without psoralens are not at an ...

Stockphoto of a newborn girl undergoing phototherapy treatment for hyperbilirubinemia, a very common newborn condition. Researchers compared 4 phototherapy methods and evaluated phototherapy duration ...

Phototherapy, also sometimes known as light therapy, involves the administration of ultraviolet radiation at certain wavelengths for medical purposes. It is often used as a treatment for psoriasis, ...